The Effects of Orange Juice on Plasma Lipids

Obesity Clinical Trial

Official title:

An Investigation Into the Effects of Orange Juice on Plasma Lipids - an Extension to J/06/2010

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01350843
• Other study ID #: RIS 100058b
• Status: Completed
• Phase: N/A
• First received: May 9, 2011
• Last updated: March 23, 2018
• Start date: May 2011
• Est. completion date: February 2013

Study information

• Verified date: March 2018
• Source: University of Nottingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is primarily to investigate the ability of antioxidants found in orange juice (OJ) to improve the serum lipid profile. Overweight or mildly obese men, who are otherwise healthy, but with elevated serum total cholesterol concentration will be recruited. The time commitment for subjects is ~14wks. Subjects will attend the laboratory on 5 occasions after fasting from midnight. The 1st is a medical screening. Laboratory visits 2 & 5 will take ~90min and will be separated by 3 months, during which time subjects will consume 250ml of an orange drink (either OJ or an orange flavoured control drink) once a day. During visits 2 & 5, subjects will have a scan to assess their %body fat using a low-dose x-ray machine, a 20ml blood sample taken and a small sample of fat tissue (about the size of a haricot bean)taken from underneath the skin of the belly. Subjects will record their food intake for 3-days in weeks 3, 7 and 11 of consuming the drink, and come to the lab for visits 3&4 during weeks 4&8. Laboratory visits 3&4 repeat measurements taken in the 1st (screening) visit.

Description:

Background:

Overweight and mild obesity are associated with insulin resistance and mild elevations in lipid risk factors which are not usually sufficiently abnormal to merit treatment. Such people are encouraged to lose weight to reduce their risk of progressing to type 2 diabetes and coronary heart disease, but there is clearly a potential role for dietary modifications to maximize any potential benefit of this weight loss. Flavonoids are known to have vascular effects which might enhance substrate delivery to metabolically active tissues, and thus improve insulin sensitivity. Moreover, there is much interest in the potentially beneficial effect of flavonoids on serum lipid profile.

There are many different dietary sources of flavonoids, with fruits such as apples, berries and citrus being rich sources. However, some researchers have expressed concern that a high dietary intake of 100% juice may contribute to the development of insulin resistance, obesity and the Metabolic Syndrome (Bazzano, Li et al. 2008), although this is not universally accepted (Fujioka, Greenway et al. 2006; O'Neil and Nicklas 2008). To date, there have been no studies investigating the effects of citrus fruits on indices of cardio-metabolic health in people who are presently healthy but are at risk of developing some features of the Metabolic Syndrome.

Aims:

To investigate the effects of orange juice (OJ) intake on appetite hormones, blood pressure and plasma lipids. In addition we aim to investigate any gene expression changes associated with OJ consumption, in particular in adipose tissue.

Experimental protocol and methods:

Overweight or obese men (BMI 27-35), who are otherwise healthy, will be recruited onto the study. They will attend the 'David Greenfield Human Physiology' laboratories on 5 convenient mornings, following an overnight fast. The 1st visit is a medical screening and will involve signing a consent form, completing medical screening, food frequency and activity questionnaires, having height, weight, and hip/waist circumference measurements taken and a sample of blood taken for CBC, urea, electrolytes, LFT, TFT, glucose and insulin analysis. Subjects will then be asked to complete a 3-day diet diary for macronutrient assessment. The 2nd visit will involve having a DEXA body composition scan, an adipose tissue biopsy and a blood sample taken for white blood cell harvest, serum lipids, glucose, insulin, cytokines, appetite hormones and catecholamine analysis. Starting on the following morning, subjects will then consume an orange drink (either OJ or a carbohydrate matched orange flavoured drink) once a day for 12 wks. A 3-day diet diary for macronutrient assessment will be recorded during wks 3,7and 11 of taking the drink, and measurements made at screening will be repeated on visits 3 and 4 which will take place in weeks 4 and 8. The final laboratory (5th) visit will be identical to visit 2.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 36
• Est. completion date: February 2013
• Est. primary completion date: December 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 40 Years to 60 Years

Eligibility

Inclusion Criteria:

• BMI 27-35

• waist circumference >96cm.

• Serum Total Cholesterol >5mmol/l

Exclusion Criteria:

• Any clinically significant metabolic or endocrine abnormalities

• screening blood results (other than lipids) outside of the normal range

• fasting total cholesterol >7.0mmol/l

• taking routine medication

• herbal supplement use

• food allergies or sensitivities related to the investigational product Regular citrus consumers (whole fruit or juice) daily consumption of sucrose or high fructose corn syrup containing soft-drinks

Related Conditions & MeSH terms

• Dyslipidemia
• Dyslipidemias
• Insulin Resistance
• Obesity

Intervention

Dietary Supplement:
• Orange Juice
250ml of orange juice or a sugars matched orange drink daily

Locations

Country	Name	City	State
United Kingdom	David Greenfield Human Physiology Unit, University of Nottingham	Nottingham	Notts

Sponsors (2)

Lead Sponsor	Collaborator
University of Nottingham	Florida Department of Citrus

Country where clinical trial is conducted

United Kingdom, 

References & Publications (4)

Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care. 2008 Jul;31(7):1311-7. doi: 10.2337/dc08-0080. Epub 2008 Apr 4. — View Citation

Fujioka K, Greenway F, Sheard J, Ying Y. The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. J Med Food. 2006 Spring;9(1):49-54. — View Citation

O'Neil CE, Nicklas TA. A review of the relationship between 100% fruit juice consumption and weight in children and adolescents. American Journal of Lifestyle Medicine 2(4): 315-354, 2008.

Simpson EJ, Mendis B, Macdonald IA. Orange juice consumption and its effect on blood lipid profile and indices of the metabolic syndrome; a randomised, controlled trial in an at-risk population. Food Funct. 2016 Apr;7(4):1884-91. doi: 10.1039/c6fo00039h. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total Serum Cholesterol concentration	Fasting Serum total cholesterol concentration (mmol/l)	after 3 months' intervention
Secondary	High Density Cholesterol (HDL)	Fasting Serum HDL concentration	after 3 months' intervention
Secondary	Low density cholesterol	Fasting Serum LDL concentration	after 3 months' intervention
Secondary	Gene expression in adipose tissue	Expression of genes related to lipid metabolism in adipose tissue	after 3 months' intervention
Secondary	leptin	fasting Serum Leptin concentration	after 3 month intervention
Secondary	IL-1	Serum IL-1 concentration	afetr 3 month intervention
Secondary	Blood Pressure	Resting blood pressure, measured semi-supine	after 3months intervention
Secondary	Ghrelin	Fasting Plasma Ghrelin concentration	After 3 months intervention
Secondary	GLP-1	Fasting Plasma GLP-1 concentration	After 3 months intervention
Secondary	insulin	Fasting serum Insulin concentration	After 3 months intervention
Secondary	IL-6	Serum IL-6 concentration	After 3 months intervention
Secondary	TNF alpha	Serum TNF-Alpha concentration	After 3 months intervention